Pharmabiz

ICMR funds new clinical trial to test effective dosing strategy of high-cost cancer drug PARP inhibitor

ICMR funds new clinical trial to test effective dosing strategy of high-cost cancer drug PARP inhibitor: Our Bureau, Mumbai Monday, December 15, 2025, 17:10 Hrs [IST] Funded by th ...
Pharmabiz

EMA recommends conditional marketing authorisation for Serum Life Science Europe’s Anktiva to treat non-muscle invasive bladder cancer

EMA recommends conditional marketing authorisation for Serum Life Science Europe’s Anktiva to treat non-muscle invasive bladder cancer: Amsterdam, The Netherland Monday, Decembe ...
Pharmabiz

Biocon Biologics inks settlement and license agreement to commercialize biosimilar aflibercept worldwide

Biocon Biologics inks settlement and license agreement to commercialize biosimilar aflibercept worldwide: Our Bureau, Bengaluru Monday, December 15, 2025, 16:45 Hrs [IST] Biocon B ...
Pharmabiz

Healthium acquires controlling stake in Paramount Surgimed, expands high-precision surgical consumables business

Healthium acquires controlling stake in Paramount Surgimed, expands high-precision surgical consumables business: Our Bureau, Bengaluru Monday, December 15, 2025, 16:10 Hrs [IST] ...
Pharmabiz

GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease

GSK’s Nucala receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease: London, UK Monday, December 15, 2025, 16:00 Hrs [IST] GSK plc announced that ...
Pharmabiz

Akums introduces enhanced gabapentin ER formulation powered by RetenEx Technology for PHN management

Akums introduces enhanced gabapentin ER formulation powered by RetenEx Technology for PHN management: Our Bureau, Chennai Monday, December 15, 2025, 15:45 Hrs [IST] Akums Drugs & ...
Pharmabiz

NIH clinical trial shows expanded umbilical cord blood transplant achieves 94% survival in severe aplastic anaemia patients

NIH clinical trial shows expanded umbilical cord blood transplant achieves 94% survival in severe aplastic anaemia patients: Maryland Monday, December 15, 2025, 15:00 Hrs [IST] A ...
Pharmabiz

University of Western Australia with AMTZ to position Visakhapatnam as a major Indo-Pacific hub for MedTech innovation

University of Western Australia with AMTZ to position Visakhapatnam as a major Indo-Pacific hub for MedTech innovation: Our Bureau, Bengaluru Monday, December 15, 2025, 14:15 Hrs ...
Pharmabiz

EMA committee recommends approval of STADA & Bio-Thera’s golimumab biosimilar Gotenfia

Thera’s golimumab biosimilar Gotenfia: Bad Vilbel, Germany Monday, December 15, 2025, 14:00 Hrs [IST] Global specialty, generic ...
Pharmabiz

Ebekme with AHPI to set up Co-Skills Hub dedicated exclusively to hospital workforce training

Ebekme with AHPI to set up Co-Skills Hub dedicated exclusively to hospital workforce training: Our Bureau, Bengaluru Monday, December 15, 2025, 13:40 Hrs [IST] Ebekmed, in collabo ...
Pharmabiz

Biocon launches its glucagon-like peptide-1, liraglutide in Netherlands

Biocon launches its glucagon-like peptide-1, liraglutide in Netherlands: Our Bureau, Bengaluru Monday, December 15, 2025, 13:30 Hrs [IST] Biocon has launch of its GLP-1 peptide, l ...
Pharmabiz

Aflibercept 8 mg recommended for marketing authorization in EU for third retinal indication

Aflibercept 8 mg recommended for marketing authorization in EU for third retinal indication: Berlin Monday, December 15, 2025, 13:00 Hrs [IST] The Committee for Medicinal Products ...